Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tamera Coyne-Beasley

Pediatrics Birmingham, AL Medical Doctor

NPI 1225055197 CMS profile 740026

1600 7Th Ave S, Birmingham, AL 35233

Open in the dashboard

General payments

$154,496

107 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tamera Coyne-Beasley of Birmingham, AL is reported in the CMS Open Payments database as having received $154,496 across 107 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,811 17
2024 General $15,120 13
2023 General $39,061 31
2022 General $32,757 26
2021 General $18,329 9
2020 General $9,790 3
2019 General $4,628 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tamera Coyne-Beasley
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Tamera Coyne-Beasley were reported at $34,811. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Tamera Coyne-Beasley Pediatrics median Middle half National median
2019 $4,628 $86 $31–$183 $163
2020 $9,790 $49 $22–$110 $114
2021 $18,329 $68 $27–$158 $132
2022 $32,757 $77 $30–$173 $149
2023 $39,061 $88 $33–$190 $160
2024 $15,120 $94 $34–$206 $164
2025 $34,811 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $80,550 55 payments
  2. Seqirus USA Inc $25,985 20 payments
  3. GlaxoSmithKline, LLC. $20,787 13 payments
  4. Dynavax Technologies Corporation $15,490 7 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $6,075 6 payments
  6. Pfizer International LLC $3,330 1 payment
  7. Sanofi Pasteur Inc. $2,040 1 payment
  8. Novo Nordisk Inc $112 1 payment
  9. Merck Sharp & Dohme Corporation $64 1 payment
  10. Biogen, Inc. $45 1 payment
  11. Other $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $77,809 31 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,940 8 payments
  3. Honoraria $25,485 11 payments
  4. Travel and Lodging $16,824 37 payments
  5. Food and Beverage $3,437 20 payments
Products named General payments · program years 2019–2025
  1. FLUCELVAX QUADRIVALENT $15,838 14 payments
  2. Heplisav-B $15,490 7 payments
  3. PREVNAR 20 Vaccines $11,732 7 payments
  4. PENBRAYA $11,549 13 payments
  5. BEXSERO $9,194 3 payments
  6. TRUMENBA $3,924 3 payments
  7. PREVNAR 20 Vaccines $3,600 1 payment
  8. PREVNAR 13 $2,960 1 payment
  9. Ozempic $112 1 payment
  10. SPINRAZA $45 1 payment
  11. Other $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

107 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record